Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
JPM24: Amgen CEO hopes to take a bite of competitive obesity market with unique approach
Fierce Pharma
Tue, 01/9/24 - 10:54 am
Amgen
Pharma CEOs
Bob Bradway
obesity
JPMHC 2024
Zealand raises $212.5M to advance obesity pipeline
Clinical Trials Arena
Tue, 01/9/24 - 09:37 am
Zealand Pharma
obesity
funding
Pfizer to remain aggressive on obesity market after setback
Reuters
Mon, 01/8/24 - 10:19 pm
Pfizer
Albert Bourla
Pharma CEOs
JPMHC 2024
obesity
Rhythm expands obesity portfolio with Phase II weight loss drug for $100m
Clinical Trials Arena
Fri, 01/5/24 - 11:21 am
Rhythm Pharmaceuticals
LG Chem
obesity
LB54640
Lilly launches website, home delivery option for weight-loss drugs
Reuters
Thu, 01/4/24 - 10:07 am
Eli Lilly
obesity
Zepbound
Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals
Fierce Biotech
Thu, 01/4/24 - 10:06 am
Novo Nordisk
Omega Therapeutics
Cellarity
Flagship Pioneering
funding
obesity
NASH
MASH
Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch
Stat
Thu, 12/21/23 - 09:52 am
obesity
climate change
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
liver disease
Lilly tames Fauna to go on the prowl for obesity targets in $494M deal
Fierce Biotech
Thu, 12/21/23 - 09:37 am
Eli Lilly
Zepbound
obesity
Fauna Bio
Structure shares sink as obesity pill misses expectations in small study
BioPharma Dive
Mon, 12/18/23 - 10:17 pm
Structure Therapeutics
obesity
clinical trial
GSBR-1290
diabetes
Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029
Biopharma Reporter
Mon, 12/18/23 - 11:37 am
Eli Lilly
Novo Nordisk
obesity
weight loss
Ozempic
Mounjaro
Teva’s Ajovy yields positive data in post-hoc migraine analysis
Clinical Trials Arena
Wed, 12/6/23 - 10:20 am
Teva Pharmaceutical
Ajovy
obesity
migraines
post-hoc analysis
Eli Lilly's obesity drug now available in U.S. pharmacies
Reuters
Tue, 12/5/23 - 09:53 am
Eli Lilly
obesity
Zepbound
pharmacies
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive
Mon, 12/4/23 - 10:18 am
Roche
Carmot Therapeutics
weight loss
obesity
M&A
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Reuters
Mon, 12/4/23 - 09:35 am
Novo Nordisk
obesity
physicians
Wegovy
Ozempic
Pfizer cans twice-daily oral obesity program after half of patients leave trial while once daily continues
Fierce Biotech
Fri, 12/1/23 - 09:50 am
Pfizer
obesity
clinical trials
danuglipron
Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News
BioSpace
Fri, 12/1/23 - 09:46 am
Altimmune
clinical trials
obesity
GLP-1 agonist
pemvidutide
Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters
BioSpace
Mon, 11/20/23 - 10:07 am
Carmot Therapeutics
obesity
IPOs
Manufacturer Lonza says it will not fill obesity drug syringes
Reuters
Fri, 11/17/23 - 10:02 am
Lonza
drug manufacturing
obesity
Novo Nordisk
Eli Lilly
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Wed, 11/15/23 - 12:04 pm
Novo Nordisk
Eli Lilly
clinical trials
CagriSema
Wegovy
Zepbound
obesity
Novo Nordisk sets aside $6bn to boost production capacity
Pharmaphorum
Fri, 11/10/23 - 10:11 am
Novo Nordisk
diabetes
obesity
drug manufacturing
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »